Inventor · disambiguated record
Nicole Gaudelli
Also filed as: GAUDELLI NICOLE · GAUDELLI NICOLE MARIE
11 granted patents·17 pending applications·427 citations·filing 2017–2024
92Inventor score
Top patents by PatentIndex Score
28 records- 0198US11999947B2Adenosine nucleobase editors and uses thereofHARVARD COLLEGE·Filed 2023·Granted Jun 4, 2024·18 cites·21 claims
- 0298US11702651B2Adenosine nucleobase editors and uses thereofHARVARD COLLEGE·Filed 2021·Granted Jul 18, 2023·29 cites·61 claims
- 0398US10947530B2Adenosine nucleobase editors and uses thereofHARVARD COLLEGE·Filed 2018·Granted Mar 16, 2021·71 cites·23 claims
- 0498US10113163B2Adenosine nucleobase editors and uses thereofHARVARD COLLEGE·Filed 2017·Granted Oct 30, 2018·249 cites·32 claims
- 0596US11344609B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·6 cites·34 claims
- 0696US11142760B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·14 cites·30 claims
- 0795US11795443B2Uses of adenosine base editorsBROAD INST INC·Filed 2018·Granted Oct 24, 2023·23 cites·39 claims
- 0895US11752202B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·3 cites·28 claims
- 0992US11155803B2Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·13 cites·30 claims
- 1081US12016908B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 1181US2025092382A1Adenosine nucleobase editors and uses thereofHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 1278US12133884B2Methods of substituting pathogenic amino acids using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2019·Granted Nov 5, 2024·1 cites·4 claims
- 1376US2025108098A1Methods of substituting pathogenic amino acids using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1476US2024132867A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1575US2024124866A1Uses of adenosine base editorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 1673US2025144149A1Adenosine deaminase base editors and methods for use thereofBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1770US2022235347A1Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1869US2024158775A1Adenosine deaminase variants and uses thereofBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1967US2025108132A1Compositions and methods for reducing complement activationBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2055US2022170027A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2154US2023075877A1Novel nucleobase editors and methods of using sameBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2253US2023101597A1Compositions and methods for treating alpha-1 antitrypsin deficiencyBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2352US2022098593A1Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2452US2022098572A1Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editorsBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2552US2022136012A1Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2651US2022127594A1Compositions and methods for treating glycogen storage disease type 1aBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2750US2021277379A1Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequenceBEAM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2847US2023140953A1Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicole Gaudelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →